Wegovy and Ozempic in India: which products are available, approved or not approved, by date

CDSCO's committee records that Wegovy has been approved in India since 20 April 2022 for chronic weight management in adults¹⁰. The approved form is a prefilled pen in 0.25, 0.5, 1.0, 1.7 and 2.4 mg¹⁰. Novo Nordisk launched it on 24 June 2025¹. PharmEasy says the FlexTouch pen gives several weekly doses, each strength being one step of the dose schedule⁸. The US label's own pen holds 4 weekly doses of 2.4 mg; that is the US pack⁷. The steps are on the semaglutide dose schedule page, and the injection on how to use semaglutide pen.

Novo Nordisk cut its Indian prices from 1 April 2026; the 2.4 mg Wegovy price did not change²².

Weekly prices with taxes, Novo Nordisk India's table of 1 April 2026 (Indian Pharma Post; BioSpectrum India)^21,22. The cut averaged about 27 % for Wegovy and 24 % for Ozempic³⁸.

Facts checked on 29 October 2026.

Yes, as a weekly injection since 24 June 2025; no, as a pill: CDSCO's committee asked Novo Nordisk for more data on it on 23 September 2026^1,4. Emcure sells the same medicine as Poviztra under a deal with Novo Nordisk announced in November 2025²⁰.

Poviztra's launch across India was reported on 22 December 2025, with Emcure as exclusive distributor¹². Emcure's launch statement priced it from ₹8,790 a month for 4 weekly doses¹². Emcure revised the prices from 3 April 2026, when the monthly MRP with taxes became ₹3,999 at 0.25 mg and ₹8,999 at 2.4 mg²⁶.

Novo Nordisk launched Ozempic in India on 12 December 2025, with the 0.25 mg weekly injection at ₹2,200, The South First reported². It is sold in 0.25, 0.5 and 1 mg for type 2 diabetes, and the 2.4 mg dose stays under the Wegovy brand, the company's India head told CNBC-TV18³. PharmEasy says Ozempic is approved in India only for type 2 diabetes and is a Schedule H medicine⁹.

Two things on the US label are not among the strengths reported in India³. One is the 2 mg weekly dose for type 2 diabetes; the other is the Ozempic tablet, in 1.5 mg, 4 mg and 9 mg^39,40. Abbott announced Extensior, a second Ozempic brand for type 2 diabetes, on 27 February 2026, with a pen in 0.25, 0.5 and 1 mg^11,36. That release said the product was expected soon; no launch has been reported since³⁶.

Is Ozempic available in India?

Yes, since 12 December 2025, for type 2 diabetes^2,3. PharmEasy says that is its only approved use here⁹.

Is Ozempic available again?

Yes. Novo Nordisk has sold Ozempic in India since 12 December 2025, and generic semaglutide has been on sale since 20 March 2026^2,27. Ozempic's price fell from 1 April 2026³⁸. In February 2026, Business Today reported that Novo Nordisk acknowledged initial supply constraints during early launch phases in India, without naming a brand, and said capacity had since been strengthened⁴¹. If you need today's stock, ask your pharmacy; our sources do not cover it.

Yes. Semaglutide, the medicine in Ozempic, is a GLP-1 receptor agonist: it binds to and switches on the receptor for GLP-1, a natural gut hormone, the US label says⁷. Cells in the gut release GLP-1 when you eat⁴². Tirzepatide, in Mounjaro and Yurpeak, switches on two receptors, GIP and GLP-1 (US label), so it is a GLP-1 medicine of a different kind^16,23,43. Two older GLP-1 medicines, dulaglutide and liraglutide, are still sold here, with about 4 % and 2 % of Indian GLP-1 sales to April 2026²⁹. The hub on semaglutide in India covers every brand.

Is Ozempic another name for semaglutide?

Ozempic is a brand name; semaglutide is the medicine inside it². Wegovy, Poviztra, Rybelsus, Obeda and the generics are other semaglutide brands sold in India^{1,13,20,32,44}.

Is GLP-1 the same as Ozempic?

No. GLP-1 is the hormone; Ozempic is one brand of one medicine that acts on its receptor^7,42. In India the same molecule is Wegovy for weight management and Ozempic for type 2 diabetes^3,10.

Is Ozempic a medicine for diabetes?

Yes. In India it is sold in 0.25, 0.5 and 1 mg for type 2 diabetes, its only approved use here according to PharmEasy^3,9.

Four molecules in our sources. Semaglutide is sold as Wegovy and Poviztra for weight management, as Ozempic for type 2 diabetes, and as Rybelsus and Obeda tablets^1,2,13,20,33. The generic brands are on the GLP-1 medicines in India page⁴⁴. Tirzepatide is sold as Mounjaro and Yurpeak; see Mounjaro in India^16,23. The older dulaglutide and liraglutide are still sold, with small shares of sales²⁹. Not available: the Wegovy pill, orforglipron, and any generic tirzepatide; Bloomberg reported tirzepatide is still under patent here^4,6,45. See semaglutide tablets in India for the tablets that do exist.

PharmEasy says every semaglutide brand sold in India, branded or generic, injection or tablet, is a Schedule H prescription medicine⁹. Rule 65 of the Drugs and Cosmetics Rules, 1945, as reproduced on Indian Kanoon, bars retail sale of a Schedule H substance except on a registered medical practitioner's prescription⁴⁶. The pharmacy must record the supply in a prescription register and write the entry's serial number on your prescription⁴⁷.

Who may write the prescription is less settled. A health-ministry release of 24 March 2026 says GLP-1 weight-loss drugs were approved on condition of prescription by endocrinologists and internal medicine specialists, and for some indications by cardiologists⁴⁸. For tirzepatide, CDSCO's expert committee recommended a specialist-only condition in 2023; that is an approval condition with no confirmed national scope⁴⁹. A government warning of March 2026, in a secondary summary of an Indian Express report, said generic semaglutide may be sold only on a registered medical practitioner's prescription⁵⁰.

The ministry's release of 24 March 2026 also says concerns had emerged about on-demand sale of generic GLP-1 drugs through pharmacies, online platforms, wholesalers and wellness clinics⁴⁸. Without medical supervision, it says, these drugs may cause serious adverse effects⁴⁸. On 10 March 2026, CDSCO's advisory prohibited surrogate advertisements and indirect promotion of GLP-1 weight-loss drugs, so no brand is recommended here⁴⁸. A PIB backgrounder advises you to consult a qualified medical specialist and to obtain these medicines on prescription through regulated channels⁵¹. To find out whether any of these medicines fits you, talk to a Zelta specialist.

In April 2026, Reuters reported that Haryana's drug regulator had seized more than 260 suspected counterfeit Mounjaro pens near New Delhi, sold on an online marketplace⁵². The primary accused had no pharmaceutical licence⁵². Reuters could not verify the official claim⁵². PharmEasy says counterfeit GLP-1 pens have been reported in India in 2026⁵³. It advises buying only on a prescription from a licensed pharmacy and avoiding unverified websites, social media and unauthorised sellers⁵³.

If you suspect a side effect from any pen, you can report it to India's Pharmacovigilance Programme (PvPI) as a patient⁵⁴. The helpline is 1800 180 3024 on working days, and the ADR PvPI Android app also takes reports^54,55. Tell your doctor as well. No maker's pen-verification method is in our sources.

What GLP-1 medications are available in India? Semaglutide as Wegovy, Poviztra, Ozempic, Rybelsus, Obeda and the generics; tirzepatide as Mounjaro and Yurpeak; and the older dulaglutide and liraglutide^{1,2,13,16,20,23,29,32,44}.

Are GLP-1 drugs available in India? Yes, on prescription; the table and the previous answer list them^9,49.

What is Ozempic used for? In India, type 2 diabetes⁹. The US label's highest dose for that use, 2 mg a week, is not reported in India^3,39.

Who manufactures Ozempic? Novo Nordisk². Abbott announced Extensior, a second brand made by Novo Nordisk, in February 2026; our sources report no launch yet^11,36.

Where can I buy Ozempic? Only on a registered medical practitioner's prescription, at a pharmacy, through regulated channels; this page names no seller^9,46,51.

Can a normal person buy Ozempic? Not without a prescription; PharmEasy lists it as Schedule H, not sold over the counter⁹.

What is the new Wegovy pill? A daily semaglutide tablet approved in the US for weight reduction, 1.5 mg to 25 mg (US label)⁷. In India, Novo Nordisk has applied to import and market it, and CDSCO's committee asked for more data on 23 September 2026^4,5.

What is the recommended dosing schedule for oral Wegovy? None for India: the pill is not approved here, and CDSCO's committee asked for more data in September 2026, so no US schedule is given⁴.

What is the price of Wegovy injection in India? From 1 April 2026, ₹1,415 a week (₹5,660 a month) at 0.25 mg and ₹4,100 a week (₹16,400 a month) at 2.4 mg, with taxes, in Novo Nordisk India's table^21,22.

What is the price of Ozempic 1 mg? ₹2,275 a week (₹9,100 a month) with taxes, from 1 April 2026, in Novo Nordisk India's price table²².